Supplemental material
Modern Rheumatology
Volume 28, 2018 - Issue 4
Open access
5,408
Views
33
CrossRef citations to date
0
Altmetric
Original Article
Efficacy and safety of baricitinib in Japanese patients with rheumatoid arthritis: Subgroup analyses of four multinational phase 3 randomized trials
Yoshiya TanakaFirst Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health, Kitakyushu, Japan; View further author information
, Tatsuya AtsumiDivision of Rheumatology, Endocrinology and Nephrology, Graduate School of Medicine, Hokkaido University, Hokkaido, Japan; View further author information
, Koichi AmanoDepartment of Rheumatology and Clinical Immunology, Saitama Medical Center, Saitama Medical University, Kawagoe, Japan; View further author information
, Masayoshi HarigaiDepartment of Epidemiology and Pharmacoepidemiology of Rheumatic Diseases, Institute of Rheumatology, Tokyo Women’s Medical University, Tokyo, Japan; View further author information
, Taeko IshiiEli Lilly Japan K.K., Kobe, Japan; View further author information
, Osamu KawaguchiEli Lilly Japan K.K., Kobe, Japan; View further author information
, Terence P. RooneyEli Lilly and Company, Indianapolis, IN, USA; View further author information
, Naotsugu AkashiEli Lilly Japan K.K., Kobe, Japan; Correspondence[email protected]
View further author information
& View further author information
Tsutomu TakeuchiDivision of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, JapanView further author information
show all
Pages 583-591
|
Received 26 Jun 2017, Accepted 08 Oct 2017, Published online: 14 Nov 2017
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.